Scientific Advisory Board
Greg Tsongalis, PhD
Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth
Dr. Tsongalis is Professor of Pathology and Director of Clinical Genomics and Advanced Technology at the Dartmouth-Hitchcock Medical Center and the Geisel School of Medicine at Dartmouth in Lebanon NH. He is a leading investigator in molecular oncology and clinical genomics. He is past president of Association of Molecular Pathology and a noted authority on molecular diagnostics. Dr. Tsongalis’ research interests include developing novel technologies and approaches for biomarker discovery and molecular pathology using Nextgen Sequencing and other advanced technologies. His clinical lab provides DNA and RNA testing for oncology, infectious diseases, pharmacogenomics and genetic diseases.
Jack Wands, MD
Lifespan Rhode Island Academic Medical Center
Brown University School of Medicine
Dr. Wands is the Chief of the Division of Gastroenterology at Lifespan Rhode Island Academic Medical Center, Director of the Liver Research Center, Professor of Medicine at Brown University School of Medicine, and Head of the Gastroenterology Section at Brown University in Providence RI. He founded and developed the Rhode Island Hospital/Brown University Liver Research Center. Dr. Wands is a highly respected and internationally recognized scientist with more than 400 scientific publications. His Research areas include hepatitis B and C etiology and treatment, pathogenesis of hepatocellular and pancreatic carcinoma.
Katherine Bianco, MD
Stanford University School of Medicine
Dr. Bianco is a Clinical Associate Professor in Obstetrics and Gynecology, Maternal Fetal Medicine at Stanford University School of Medicine in Palo Alto CA. She is a an expert clinical scientist studying the fundamental aspects of trophoblast biology using human trophoblast progenitor cell (TBPC) lines derived from aneuploid placentas. She is a practicing Obstetrics & Gynecology physician specializing in birth defect and fetal treatment and high risk maternal fetal medicine.
Errol Norwitz, MD, PhD
Tufts University School of Medicine
Dr. Norwitz is Professor and Chairman, Department of Obstetrics and Gynecology Tufts University School of Medicine in Boston Mass. He is internationally recognized for his work in maternal-fetal medicine, particularly in the causes and prevention of preeclampsia and pre-term labor. His research includes the use of progesterone to delay preterm labor in high-risk women, the genetics of adverse pregnancy outcomes, and the molecular regulation of labor and delivery, both term and preterm. Dr. Norwitz is on the Tufts Research Council and is Editor-in-Chief, Reviews in Obstetrics & Gynecology.
Jonathan Li, MD
Harvard Medical School
Brigham and Women's Hospital
Dr. Li is an Assistant Professor of Medicine at Harvard Medical School and a faculty member in the Division of Infectious Diseases at the Brigham and Women’s Hospital Boston MA. His research is focused on HIV drug resistance, persistence, and vaccines. He is well known for his original research in HIV minority variants using next-generation sequencing, HIV integration into the human genome and Correlates of HIV neurocognitive impairment. He is active in the AIDS Clinical Trials Group (ACTG) as a member of the ACTG HIV Reservoirs and Viral Eradication Transformative Science Group and as the Chair of several ACTG clinical trials.